Dashboard
Manage Tickers

NERV Minerva Neurosciences, Inc.

Nasdaq minervaneurosciences.com


$ 4.65 $ -0.17 (-3.49 %)    

Friday, 24-Oct-2025 19:43:27 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 4.7
$ 4.53
$ 4.58 x 2,005
$ 5.00 x 30
$ 4.50 - $ 5.10
$ 1.15 - $ 12.46
881,624
na
32.87M
$ 0.25
$ 2.93
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 02-25-2025 12-31-2024 10-K
4 11-05-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-01-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-08-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-02-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-08-2021 12-31-2020 10-K
20 11-02-2020 09-30-2020 10-Q
21 08-03-2020 06-30-2020 10-Q
22 05-04-2020 03-31-2020 10-Q
23 03-09-2020 12-31-2019 10-K
24 11-04-2019 09-30-2019 10-Q
25 08-05-2019 06-30-2019 10-Q
26 05-06-2019 03-31-2019 10-Q
27 03-12-2019 12-31-2018 10-K
28 11-05-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-03-2018 03-31-2018 10-Q
31 03-12-2018 12-31-2017 10-K
32 11-06-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 03-13-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 03-14-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 17:06:27

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 21:06:33

minerva-stock-rises-after-securing-200m-for-schizophrenia-drug-trial
Minerva Stock Rises After Securing $200M f...
10/21/2025 19:11:06

Minerva Neurosciences Inc (NASDAQ:NERV) shares are climbing Tuesday after the company announced up to $200 million in funding t...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 17:06:45

us-stocks-mixed-coca-cola-posts-upbeat-earnings
US Stocks Mixed; Coca-Cola Posts Upbeat Ea...
10/21/2025 13:50:36

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 12:10:04

minerva-neurosciences-announces-up-to-200m-in-financing-to-advance-roluperidone-for-schizophrenia-through-phase-3-confirmatory-trial-and-nda-resubmission
Minerva Neurosciences Announces Up To $200...
10/21/2025 12:02:23

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/14/2025 21:06:20

minerva-neurosciences-q2-eps-043-beats-090-estimate
Minerva Neurosciences Q2 EPS $(0.43) Beats...
08/14/2025 20:37:00

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of...

minerva-neurosciences-q1-eps-050-beats-107-estimate
Minerva Neurosciences Q1 EPS $(0.50) Beats...
05/13/2025 11:37:28

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/14/2025 21:06:19

hc-wainwright--co-reiterates-neutral-on-minerva-neurosciences-maintains-5-price-target
HC Wainwright & Co. Reiterates Neutral on ...
02/26/2025 12:32:50

HC Wainwright & Co. analyst Douglas Tsao reiterates Minerva Neurosciences (NASDAQ:NERV) with a Neutral and maintains $5 ...

minerva-neurosciences-q4-2024-gaap-eps-056-beats-105-estimate-cash-cash-equivalents-and-restricted-cash-at-december-31-2024-were-approximately-215m
Minerva Neurosciences Q4 2024 GAAP EPS $(0...
02/25/2025 12:14:18

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of...

hc-wainwright--co-reiterates-neutral-on-minerva-neurosciences-maintains-5-price-target
HC Wainwright & Co. Reiterates Neutral on ...
11/06/2024 11:56:35

HC Wainwright & Co. analyst Douglas Tsao reiterates Minerva Neurosciences (NASDAQ:NERV) with a Neutral and maintains $5 ...

minerva-neurosciences-q3-2024-gaap-eps-297-may-not-be-comparable-to-101-estimate
Minerva Neurosciences Q3 2024 GAAP EPS $2....
11/05/2024 13:04:17

Minerva Neurosciences (NASDAQ:NERV) reported quarterly earnings of $2.97 per share which may not be comparable to analyst conse...

hc-wainwright--co-maintains-neutral-on-minerva-neurosciences-lowers-price-target-to-5
HC Wainwright & Co. Maintains Neutral on M...
08/07/2024 20:21:42

HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the pri...

minerva-neurosciences-q2-2024-gaap-eps-109-misses-073-estimate-cash-cash-equivalents-and-restricted-cash-at-june-30-2024-were-approximately-31m
Minerva Neurosciences Q2 2024 GAAP EPS $(1...
08/06/2024 11:43:05

hc-wainwright--co-maintains-neutral-on-minerva-neurosciences-lowers-price-target-to-7
HC Wainwright & Co. Maintains Neutral on M...
05/02/2024 17:31:53

HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the pri...

minerva-neurosciences-q1-2024-gaap-eps-113-beats-120-estimate-cash-cash-equivalents-and-restricted-cash-of-349m
Minerva Neurosciences Q1 2024 GAAP EPS $(1...
05/01/2024 12:16:52

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(1.13) per share which beat the analyst consensus estimate of...

minerva-neurosciences-on-april-10-got-notice-from-nasdaq-that-company-was-not-in-compliance-with-nasdaqs-listing-rule
Minerva Neurosciences On April 10, Got Not...
04/12/2024 20:15:04

-SEC Filing

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION